(Q35775400)

English

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

scientific article published on 14 September 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

invasive candidiasis

1 reference

based on heuristic

inferred from title

11

object named as

Elie Azoulay

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

8

object named as

Jean-Paul Mira

0 references

Jean-François Timsit

12

object named as

Jean-François Timsit

0 references

Didier Guillemot

object named as

Didier Guillemot

6

0 references

Olivier Lortholary

7

object named as

Olivier Lortholary

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Sébastien Bailly

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Olivier Leroy

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Philippe Montravers

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Jean-Michel Constantin

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Hervé Dupont

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Pierre-François Perrigault

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Jean-Pierre Gangneux

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Intensive Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1931-1940

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Septic shock attributed to Candida infection: importance of empiric therapy and source control

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Evaluation of bactec mycosis IC/F and Plus Aerobic/F blood culture bottles for detection of Candida in the presence of antifungal agents

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Management bundles for candidaemia: the impact of compliance on clinical outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Doubly robust estimation in missing data and causal inference models

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Contrasting treatment-specific survival using double-robust estimators

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Doubly robust estimation of causal effects

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Isolation of cholesterol-dependent, multidrug-resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

1 reference

https://api.crossref.org/works/10.1007%2FS00134-015-4053-1

21 January 2018

Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/26370688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26370688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/26370688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://pubmed.ncbi.nlm.nih.gov/26370688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00134-015-4053-1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35775400&oldid=2197725462"